Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile Todd C. Crawford, MD, Joshua C. Grimm, MD, J.

Slides:

Advertisements

Similar presentations

The Registry of the International Society for Heart and Lung Transplantation: Thirty- second Official Adult Lung and Heart-Lung Transplantation Report—2015;

Advertisements

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis Eric S. Weiss, MD, MPH, Jeremiah G. Allen,

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting

What Predicts Long-Term Survival After Heart Transplantation

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Mauer Biscotti, MD, Whitney D

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M

Late Vascular Complications After Extracorporeal Membrane Oxygenation Support Daniel Zimpfer, MD, Birgit Heinisch, MD, Martin Czerny, MD, Thomas Hoelzenbein,

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Variation in Red Blood Cell Transfusion Practices During Cardiac Operations Among Centers in Maryland: Results From a State Quality-Improvement Collaborative

Trevor Williams, MD, MPH, Brian C

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Philip J Wolfson, MD The Annals of Thoracic Surgery

Outcome of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation and Graft Recovery Hartmuth B. Bittner, MD, PhD, Sven Lehmann, MD,

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations Giovanni Filardo, PhD, MPH, Paul.

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Rika E. Ohkuma, MD, Todd C. Crawford, MD, Patricia M

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A

Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation Shahrokh.

Less Is More: Results of a Statewide Analysis of the Impact of Blood Transfusion on Coronary Artery Bypass Grafting Outcomes Todd C. Crawford, MD, J.

Castigliano M. Bhamidipati, DO, MS, George J

Complications After Cardiac Operations: All Are Not Created Equal

Michael Eberlein, MD, PhD, Robert M

Hanan A. Tanash, PhD, Gerdt C. Riise, PhD, Magnus P

New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton,

The Survival Benefit of Simultaneous Heart-Kidney Transplantation Extends Beyond Dialysis-Dependent Patients Arman Kilic, MD, Joshua C. Grimm, MD, Glenn.

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Outcomes of Intraoperative Venoarterial Extracorporeal Membrane Oxygenation Versus Cardiopulmonary Bypass During Lung Transplantation Christian A. Bermudez,

Trevor Williams, MD, MPH, Brian C

Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher.

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Jeremiah R. Brown, PhD, Richard P. Cochran, MD, Todd A

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Development and Validation of a Score to Predict the Risk of Readmission After Adult Cardiac Operations Arman Kilic, MD, Jonathan T. Magruder, MD, Joshua.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

PaO2/FiO2 Deterioration During Stable Extracorporeal Membrane Oxygenation Associates With Protracted Recovery and Increased Mortality in Severe Acute.

Lung Function and ECMO After Lung Transplantation

The Simplified Acute Physiology Score II as a Predictor of Mortality in Patients Who Underwent Extracorporeal Membrane Oxygenation for Septic Shock Myung.

Fernando Fleischman, MD, Ramsey S. Elsayed, MD, Robbin G

Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts? Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,

Acute Kidney Injury Increases Mortality After Lung Transplantation

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Assessment of Different Threshold Preoperative Glomerular Filtration Rates as Markers of Outcomes in Lung Transplantation Asishana A. Osho, MPH, Anthony.

Postoperative Extracorporeal Membrane Oxygenation Support for Acute Type A Aortic Dissection Ting-Wei Lin, MD, MS, Meng-Ta Tsai, MD, Yu-Ning Hu, MD,

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

William M. Whited, MD, Paul Henley, BS, Erin M

The Impact of 22q11.2 Deletion Syndrome on Surgical Repair Outcomes of Conotruncal Cardiac Anomalies Bahaaldin Alsoufi, MD, Courtney McCracken, PhD,

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting

Sharven Taghavi, MD, MPH, Senthil N

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction David A. Cotoni, DO, Robert T. Palac, MD,

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Completeness of Revascularization and Survival Among Octogenarians With Triple- Vessel Disease Siamak Mohammadi, MD, Dimitri Kalavrouziotis, MD, Francois.

Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation Joshua C. Grimm, MD, Vicente Valero, MD, Arman.

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

A Risk Score to Predict Acute Renal Failure in Adult Patients After Lung Transplantation Joshua C. Grimm, MD, Cecillia Lui, BSE, Arman Kilic, MD, Vicente.

Christian A. Bermudez, MD, Rodolfo V

Variation in mortality risk factors with time after coronary artery bypass graft operation Dexiang Gao, PhD, Gary K Grunwald, PhD, John S Rumsfeld, MD,

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Body Mass Index and Outcome After Ventricular Assist Device Placement

Presentation transcript:

Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile Todd C. Crawford, MD, Joshua C. Grimm, MD, J. Trent Magruder, MD, Jinny Ha, MD, Christopher M. Sciortino, MD, Bo S. Kim, MD, Errol L. Bush, MD, John V. Conte, MD, Robert S. Higgins, MD, Ashish S. Shah, MD, Christian A. Merlo, MD The Annals of Thoracic Surgery Volume 103, Issue 5, Pages 1607-1613 (May 2017) DOI: 10.1016/j.athoracsur.2016.11.057 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier survival analysis for lung transplant recipients 30 days after transplantation. The differences in probability of survival in more recent eras did not reach statistical significance (log rank p = 0.152). The Annals of Thoracic Surgery 2017 103, 1607-1613DOI: (10.1016/j.athoracsur.2016.11.057) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier survival analysis for lung transplant recipients 1 year after transplantation. There is a statistically significant difference in survival probability for recipients receiving transplants in more recent eras (log rank p = 0.001). The Annals of Thoracic Surgery 2017 103, 1607-1613DOI: (10.1016/j.athoracsur.2016.11.057) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Predictors of 30-day mortality (left) and the unadjusted and adjusted impact of transplantation era on 30-day mortality (right). Era 2 = January 1, 2009, to December 31, 2011; Era 3 = January 1, 2012, to March 31, 2014. (BMI = body mass index; CF = cystic fibrosis; CI = confidence interval; COPD = chronic obstructive pulmonary disease; ECMO = extracorporeal membrane oxygenation; HR = hazard ratio; KPS = Karnofsky performance status; LL = lower limit; UL = upper limit.) The Annals of Thoracic Surgery 2017 103, 1607-1613DOI: (10.1016/j.athoracsur.2016.11.057) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Predictors of 1 year mortality (left) and the unadjusted and adjusted impact of transplant era on 1 year mortality (right). Era 2 = January 1, 2009, to December 31, 2011; Era 3 = January 1, 2012, to March 31, 2014. (BMI = body mass index; CF = cystic fibrosis; CI = confidence interval; COPD = chronic obstructive pulmonary disease; ECMO = extracorporeal membrane oxygenation; GFR = glomerular filtration rate; HR = hazard ratio; ICU = intensive care unit; KPS = Karnofsky performance status; LL = lower limit; UL = upper limit.) The Annals of Thoracic Surgery 2017 103, 1607-1613DOI: (10.1016/j.athoracsur.2016.11.057) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions